Tag: PRMT5 inhibitor program
Victorian research centre inks major pharma deal
The Australian Cancer Therapeutics Cooperative Research Centre (CTx), their UK based research and commercialisation partner Cancer Research Technology (CRT) and global pharmaceutical giant MSD...
Featured Article
Forecasting the future: GridBeyond’s new tool supports smarter energy planning
As Australia’s energy landscape grows more dynamic, businesses operating in the National Electricity Market (NEM) face increasing challenges – from rising costs and evolving regulations to the growing presence of decentralised and renewable energy sources.
